Adaptive Biotechnologies Corporation

ADPT | NASDAQ

$27.86

-$0.75 (-2.62%)

At close: Sep 21, 2026, 4:00 PM ET

$27.23

-$0.63 (-2.28%)

Pre-market: Sep 22, 2026, 8:46 AM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	276.98M	178.96M	170.28M	185.31M	154.34M	98.38M
Cost of Revenue	71.36M	72.08M	75.55M	57.91M	49.3M	22.53M
Gross Profit	205.62M	106.88M	94.72M	127.4M	105.04M	75.85M
Operating Income	-57.12M	-162.55M	-227.04M	-200.19M	-208.97M	-152.82M
Interest Income	9.44M	14.53M	15.53M	4.06M	1.67M	6.59M
Pretax Income	-59.46M	-159.6M	-225.3M	-200.37M	-207.3M	-146.23M
Net Income	-59.5M	-159.49M	-225.25M	-200.19M	-207.28M	-146.23M
Selling & General & Admin	167.27M	157.57M	172.51M	184.13M	169.97M	110.89M
Research & Development	93.77M	102.95M	122.12M	141.76M	142.34M	116.07M
Other Expenses	1.7M	8.91M	27.13M	1.7M	1.7M	1.7M
Operating Expenses	262.74M	269.43M	321.76M	327.59M	314.01M	228.67M
Interest Expense	11.78M	11.58M	13.8M	4.24M	n/a	n/a
Selling & Marketing Expenses	94.57M	84.76M	88.58M	95.6M	95.47M	61.36M
Cost & Expenses	334.1M	341.51M	397.31M	385.49M	363.31M	251.2M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	151.72M	147.1M	144.38M	142.52M	140.35M	131.22M
Shares Outstanding (Diluted)	151.72M	147.1M	144.38M	142.52M	140.35M	131.22M
EPS (Basic)	-0.39	-1.08	-1.56	-1	-1.46	-1.06
EPS (Diluted)	-0.39	-1.08	-1.56	-1	-1.46	-1.06
EBITDA	-29.85M	-128.76M	-189.27M	-175.21M	-193.35M	-144.35M
EBIT	-47.68M	-148.02M	-211.5M	-196.13M	-207.3M	-152.82M
Depreciation & Amortization	17.83M	19.26M	22.23M	20.92M	13.95M	8.47M